The study of psoriasis has yielded fundamental new insights into immunologic regulation
and innovative therapies in a way that few other diseases have. In this review, we …

Die Erforschung kaum einer anderen Erkrankung hat so grundlegend neue Erkenntnisse
über immunologischen Regulationen und gleichzeitig eine derart rasante Entwicklung …

Zusammenfassung Hintergrund Biologika, die die Interleukine IL‐23 and IL‐17 hemmen,
haben sich in der Behandlung der mittelschweren bis schweren Psoriasis als sicher und …

The dysfunctionality of the protective skin barrier in psoriasis allows easier cutaneous
penetration of various contact haptens; thus, such patients can develop allergic contact …

Hidradenitis suppurativa (HS) is a chronic skin condition that significantly impacts patients'
quality of life. HS is often challenging to treat. In this review, we discuss the unique …

Pathologists provide valuable input in the dermatological care of pregnant patients in
various contexts. This article provides dermatopathology updates on cutaneous changes …

Background: Ustekinumab is an interleukin 12/23 inhibitor, approved by the US-FDA for the
management of moderate-to-severe plaque psoriasis and psoriatic arthropathy. Purpose …

Management of Hidradenitis Suppurativa during Pregnancy and Lactation | Current Dermatology
Reports Skip to main content SpringerLink Account Menu Find a journal Publish with us Track …

Psoriasis is a common inflammatory skin condition with an estimated prevalence of 1.5% in
the United Kingdom. Its management has evolved rapidly over the last 15 years as our …

Generalized pustular psoriasis of pregnancy (GPPP) is a rare dermatological condition that
significantly affects maternal health and pregnancy outcomes. The treatment of this disease …